Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase alpha 11, pseudogene (GSTA11P; also GSTAP3) is a non-protein-coding member of the alpha class GST gene family[5]. Unlike canonical GST alpha enzymes (such as GSTA1 and GSTA2), GSTA11P is a genomic sequence with high similarity to GST alpha genes but lacks protein-coding capability and does not have enzyme activity. Pseudogenes like GSTA11P arise from duplication or mutation events in gene families but have accumulated changes that prevent translation into functional protein. GSTA11P is not included in lists of functional GST alpha enzymes, and there is no evidence to suggest it plays a role in detoxification, drug metabolism, or other physiological pathways[1][5]. It is not a therapeutic target, and its mention should generally be restricted to genomic studies or discussions of GST gene family evolution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase alpha 11, pseudogene (GSTA11P).